FRA:MED - Deutsche Boerse Ag - DE0006595101 - Common Stock - Currency: EUR
MEDICLIN AG
FRA:MED (2/3/2025, 7:00:00 PM)
3
+0.1 (+3.45%)
The current stock price of MED.DE is 3 EUR. In the past month the price increased by 21.95%. In the past year, price increased by 3.45%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.18B | ||
EMEIS.PA | EMEIS SA | 1.05 | 1.05B | ||
RHK.DE | RHOEN-KLINIKUM AG | 21.94 | 984.31M | ||
CLARI.PA | CLARIANE SE | N/A | 835.13M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 14.05 | 481.67M | ||
M12.DE | M1 KLINIKEN AG | 17.59 | 293.62M | ||
LNA.PA | LNA SANTE | 9.36 | 234.55M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 101.50M | ||
MAK.DE | MATERNUS-KLINIKEN AG | N/A | 36.28M | ||
EIF.DE | MEDNATION AG | 1.29 | 4.12M |
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 6,882 full-time employees. The company went IPO on 2000-12-04. The firm is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. The company focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
MEDICLIN AG
Okenstr. 27
Offenburg BADEN-WUERTTEMBERG DE
Employees: 6882
Company Website: https://www.mediclin.de/
Investor Relations: http://www.mediclin.de/en/investor-relations/financial-publications
Phone: 497814880
The current stock price of MED.DE is 3 EUR.
The exchange symbol of MEDICLIN AG is MED and it is listed on the Deutsche Boerse Ag exchange.
MED.DE stock is listed on the Deutsche Boerse Ag exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MED.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MED.DE.
MED.DE does not pay a dividend.
MED.DE does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).
ChartMill assigns a technical rating of 9 / 10 to MED.DE. When comparing the yearly performance of all stocks, MED.DE is one of the better performing stocks in the market, outperforming 84.46% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MED.DE. MED.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months MED.DE reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by -154.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.23% | ||
ROE | -5.26% | ||
Debt/Equity | 2 |
ChartMill assigns a Buy % Consensus number of 83% to MED.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 352% and a revenue growth 0.09% for MED.DE